SOA Wealth Advisors’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
AWM
JIC
AWM
SS
EWA
TWC
SIC
MG
HPC
GSWM
SOA Wealth Advisors's FLNA Position: Q2 2026 in Review
SOA Wealth Advisors held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 78 shares worth $93. The position accounts for ﹤0.01% of the portfolio, ranked #866.
SOA Wealth Advisors first reported a position in FLNA in Q4 2020 and has held it in 23 quarters since. The position peaked at $25K in Q3 2022. 15 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.
- SOA Wealth Advisors held 78 shares of Filana Therapeutics worth $93 as of Q2 2026.
- SOA Wealth Advisors left its Filana Therapeutics share count unchanged in Q2 2026.
- Filana Therapeutics made up ﹤0.01% of SOA Wealth Advisors's portfolio in Q2 2026, its #866 holding.
- SOA Wealth Advisors first reported a position in Filana Therapeutics in Q4 2020 and has held it in 23 quarters since.
- SOA Wealth Advisors's Filana Therapeutics position peaked at $25K in Q3 2022.
- 15 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.
Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.